CE DAYTIME SESSIONS
NO ECHO-NO PROBLEM: STAGING MMVD Sonya Gordon, DVM, DACVIM Cardiology 2:00 PM - 2:50 PM | Ballroom B Myxomatous mitral valve disease (MMVD) is the most common cause of canine heart disease accounting for approximately 75% of all canine heart disease. Asymptomatic dogs with sufficient cardiomegaly 2nd to MMVD (Stage B2) benefit from pimobendan treatment. Echocardiography is the gold standard test for diagnosis and staging preclinical MMVD but may not be available in all practices and in some cases may be cost prohibitive. Thoracic radiographs alone or in combination with other clinical information can be used to discriminate between Stage B1 and B2 MMVD when echocardiography is not available. MEWOW! LEARN HOW TO DIAGNOSE, STAGE AND TREAT FELINE CARDIOMYOPATHY Sonya Gordon, DVM, DACVIM Cardiology 3:00 PM - 3:50 PM | Ballroom B Cardiomyopathies (CM) represent primary diseases of the myocardium that are characterized by a variety of phenotypes that may or may not be progressive and thus may or may not lead to the development of clinical signs. Other comorbid conditions, such as systemic hypertension and hyperthyroidism, can mimic feline CM and/or contribute to progression if left unmanaged in cats with CM, and thus should always be ruled-out in cats with known or suspected CM (Stage A through D). Initial clinical signs of CM can be acute and life threatening. Clinical signs associated with feline CM include those associated with congestive heart failure (CHF), arterial thromboembolism (ATE). This session will emphasize practical recommendations for screening, diagnosis and staging and treatment of CM. Emphasis will be on hypertrophic and hypertrophic obstructive cardiomyopathy. Key aspects of the ACVIM CM guidelines will be highlighted. WHAT DO I NEED TO KNOW ABOUT PULMONARY HYPERTENSION IN DOGS? Sonya Gordon, DVM, DACVIM Cardiology 4:30 PM - 5:20 PM | Ballroom B Pulmonary hypertension is an important cause of morbidity and mortality in the dog and is associated with many common canine diseases (MMVD, airway disease, Cushing’s disease etc.). In general, there are numerous etiologies of pulmonary hypertension (PH) which may be linked by a single unifying hypothesis: PH develops in dogs with an underlying genetic predisposition following exposure to specific stimuli(ae) which serve as triggers. These triggers can be grouped into categories based on common pathobiological features. Knowledge of these categories will aid in diagnosis and treatment of PH in dogs. This session will present a practical overview of PH in the dog with emphasis on the current ACVIM guidelines. SUNDAY, SEPTEMBER 29 _______________________________________ ONCOLOGY DIAGNOSTICS - HISTORICAL TESTS AND NEW APPROACHES Bobbi McQuown, DVM 8:00 AM - 8:50 AM | Ballroom B There are many aids in diagnosing cancer including simple lab work, radiographs, and tumor sampling. We will discuss how to utilize these historical tests and incorporate newer tests to complete the diagnosis. Often a combination of tests provides additional information regarding the prognosis and treatment options for a patient. CANINE LYMPHOMA: WHAT WE KNOW AND WHAT WE CONTINUE TO LEARN Bobbi McQuown, DVM 9:00 AM - 9:50 AM | Ballroom B Canine lymphoma is the most common cancer in dogs. We have an understanding of how it presents, how it progresses, and how to treat. However, this understanding is evolving and there are important differences to understand regarding how a patient may respond to treatment and how this may impact their prognosis. We will discuss diagnostics, staging, treatment options, and outcomes. Leading Specialty Healthcare for Pets Leading Specialty Healthcare for Pets
FELINE UPPER AND LOWER URINARY STONES Catriona MacPhail, DVM, PhD, DACVS 2:00 PM - 2:50 PM | Ballroom A Multiple treatment options for feline urinary bladder stones will be presented, and then attention will be turned to the routine simple cystotomy and possible complications. A brief discussion will follow regarding available options for cats with ureteral obstruction. WHAT IS IN THE CAT'S PLEURAL SPACE? AIR? FLUID? ORGANS? - PART 1 Catriona MacPhail, DVM, PhD, DACVS 3:00 PM - 3:50 PM | Ballroom A Air, fluid, or tissue can compromise the pleural space and cause an acute respiratory crisis in cats. This session will discuss the etiology, recognition, and management of pleural space disease, specifically with regards to trauma resulting in diaphragmatic herniation. Surgical timing of acute traumatic diaphragmatic hernias will be discussed along with unique concerns in cats with chronic diaphragmatic herniation. WHAT IS IN THE CAT'S PLEURAL SPACE? AIR? FLUID? ORGANS? - PART 2 Catriona MacPhail, DVM, PhD, DACVS 4:30 PM - 5:20 PM | Ballroom A Air, fluid, or tissue can compromise the pleural space and cause an acute respiratory crisis in cats. This session will discuss the etiology, recognition, management, and prognosis of pleural space disease, specifically with regards to spontaneous pneumothorax, pyothorax and chylothorax. ADVANCED HEMATOLOGY: DISSECTING THE Diagnostic blood work and its proper interpretation are vital in diagnosing and managing sick patients. In this case-based talk, I will highlight key changes in the hemogram that must be assessed to provide essential diagnostic information. We will discuss the appropriate evaluation of anemia, the importance of manual WBC differentials in recognizing inflammation and toxic change, and the investigation of reported thrombocytopenia. Pairing of various cytograms, important microscopic findings, and ancillary diagnostics will allow for further interpretation of the automated data that is key to understanding disease and case management. INTERPRETING THE BIOCHEMICAL PROFILE: IMPORTANT PATTERNS YOU DON'T WANT TO MSS Holly Brown, DVM, PhD, DACVP 3:00 PM - 3:50 PM | Ballroom C This case-based session will review patterns in the biochemical data from commonly encountered disease processes and the ancillary diagnostics that ensue, both from in-clinic testing and from the reference lab. Tying together the data from the chemistry panel to the rest of the minimum database will provide appropriate interpretation and allow for proper case management. URINALYSIS ESSENTIALS: IMPORTANT TIPS TO MAXIMIZE THE DIAGNOSTIC INFORMATION DATA & BLOOD FILM REVIEW Holly Brown, DVM, PhD, DACVP 2:00 PM - 2:50 PM | Ballroom C Urinalysis is an essential clinical test and too often overlooked or undervalued in diagnosing and managing our clinical cases. Including urinalysis in the minimum laboratory database is essential for complete and appropriate interpretation of a patient’s laboratory data and proper medical management. Interesting cases will be discussed in which the complete urinalysis is reviewed, including tips both for technique and interpretation, to provide vital diagnostic information. Holly Brown, DVM, PhD, DACVP 4:30 PM - 5:20 PM | Ballroom C
CANINE ORAL TUMORS - APPROACH TO DIAGNOSIS AND TREATMENT Bobbi McQuown, DVM 10:00 AM - 10:50 AM | Ballroom B Oral tumors are common in dogs and may be found incidentally or due to clinical signs. There are important things to consider before treatment regarding behavior and prognosis. The treatment of oral tumors may include surgery, radiation, and/ or systemic therapy. We will discuss the most common oral tumors and how to move forward with staging and treatment. CANINE MAST CELL TUMORS - ABOVE AND
Leading Specialty Healthcare for Pets
BEYOND THE GRADE Bobbi McQuown, DVM 11:00 AM - 11:50 AM | Ballroom B
Leading Specialty Healthcare for Pets
Canine mast cell tumors are the most common skin tumor in dogs. There is an abundant amount of information available to help predict the behavior. We will discuss how to combine the assessment of the mass on the patient with the biopsy results and how best to proceed with staging for an individual case. Based on the combination of this data, we will review options for mast cell tumor treatment. We will discuss novel treatment options for canine mast cell tumors and when to consider their application. CURRENT TRENDS IN GASTROINTESTINAL PARASITES OF COMPANION ANIMALS Guilherme Verocai, DVM, MS, PhD, DACVM (Parasitology) 8:00 AM - 8:50 AM | Room 201 AB Helminths and protozoan parasites of the gastrointestinal (GI) tract of companion animals are common and widespread. The biology, clinical relevance and epidemiology of selected GI parasites will be examined, including local and regional trends. Recommendations for prevention, diagnostic and control will be discussed. WHAT’S NEW ON DIAGNOSTICS OF GASTROINTESTINAL PARASITES IN COMPANION ANIMALS? Guilherme Verocai, DVM, MS, PhD, DACVM (Parasitology) 9:00 AM - 9:50 AM | Room 201 AB Helminths and protozoan parasites of the gastrointestinal (GI) tract of companion animals remain commonly found across the country, despite current diagnostic and therapies available. The various diagnostic modalities used to detect GI parasitic infections will be examined. Commercially available diagnostic tests will be discussed, with strong emphasis on the various recent innovations in the field. WORMS FIGHTING BACK: AN UPDATE ON CANINE HOOKWORM RESISTANCE Guilherme Verocai, DVM, MS, PhD, DACVM (Parasitology) 10:00 AM - 10:50 AM | Room 201 AB The canine hookworm, Ancylostoma caninum, is among the most common gastrointestinal parasites of dogs across the United States. Recently, the emergence of anthelmintic resistance in canine hookworms have been described. In fact, strains that might be resistance to all three drug classes currently approved for preventing and treating hookworm infections have been characterized. Current recommendations on diagnostics and management of suspected resistant cases will be discussed. Trends in distribution and prevalence of multi-anthelmintic drug resistance will be assessed, highlighting the existing diagnostic limitations and research needs.
www.swvs.org 50
Made with FlippingBook - professional solution for displaying marketing and sales documents online